Evidence map›Paper›PMID 29436433›Full record

ReviewClinical medicine (London, England)2018

Updates in palliative care - recent advancements in the pharmacological management of symptoms.

Angela Star, Jason W Boland

Open access · diamondAbstract readReview
In one paragraph

Review in Clinical medicine (London, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 41 citations in OpenAlex.

  1. Application of interdisciplinary collaborative hospice care for terminal geriatric cancer patients: a prospective randomized controlled study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Trial
  2. Article
  3. Article
  4. Article
  5. Gastro-Intestinal Symptoms in Palliative Care Patients.Current oncology (Toronto, Ont.) · 2024
    Review
  6. High-quality phase 3 studies do not support the use of somatostatin analogues to reduce vomiting in malignant bowel obstruction.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Article
  7. Review
  8. Article
  9. End-of-life care: Updates for busy clinicians.Clinical medicine (London, England) · 2018
    Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Angela StarSheffield Teaching Hospitals, Sheffield, UK angela.star@sth.nhs.uk.
Jason W BolandWolfson Palliative Care Research Centre, Hull York Medical School, University of Hull, Hull, UK.
Hull York Medical School · GBSheffield Teaching Hospitals NHS Foundation Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Symptom management is an important part of both palliative care and end-of-life care. This article will examine the recent research evidence about drugs commonly used for symptom management in adult patients receiving palliative care. In particular, the management of symptoms where recent palliative care-based evidence has changed recommended practice will be reviewed. This includes: breathlessness, delirium, nausea and vomiting in bowel obstruction, opioid-induced constipation and upper respiratory tract secretions. For each symptom, a review of recent pharmacological evidence has been undertaken, with emphasis on potential important changes to physicians' practice.

Indexed as

Medication Therapy ManagementTerminally IllHumansPalliative CareSymptom AssessmentTerminal Carebreathlessnessdeliriummalignant bowel obstructionPalliative caresymptom management

Identifiers

PMID29436433
PMCPMC6330925
OpenAlexW2786060768

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.